Aptose Biosciences Inc. secured $4.43 million in funding through a registered direct offering for working capital and general corporate use.
Amount Raised
$4.43 Million
Round Type
Seed
San DiegoBiotechnologyHealth CareMedicalTherapeuticsresearchInvestors
Description
Aptose Biosciences Inc. has completed a registered direct offering, raising approximately $4.43 million by selling common shares at $1.15 each, as well as issuing series A and B warrants. The funding is intended for working capital and general corporate use.
Quick answer
Aptose Biosciences raised $4.43 Million in a Seed round, dated June 3, 2024. Investors: H.C. Wainwright & Co. Aptose Biosciences is based in San Diego, California, United States.
- How much did Aptose Biosciences raise?
- Aptose Biosciences raised $4.43 Million in a Seed round on June 3, 2024.
- Who invested in Aptose Biosciences?
- H.C. Wainwright & Co. is named as investors in this round.
- What does Aptose Biosciences do?
- Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address unmet clinical need in multiple hematologic malignancies.
- Where is Aptose Biosciences based and how big is it?
- Aptose Biosciences is based in San Diego, California, United States. Fundz records about 35 employees.
- Who are the decision-makers at Aptose Biosciences?
- Fundz holds 1 contact at Aptose Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Aptose Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Scorpion Therapeutics raised $150M (Series C) on July 16, 2024.
- Scorpion Therapeutics raised $126M on July 1, 2024.
- N-Power Medicine raised $72M (Series B) on July 1, 2024.
- Cognito Therapeutics raised $10M on June 18, 2024.
- Grey Wolf Therapeutics raised $50M (Series B) on May 23, 2024.
- Novocure raised $400M (Debt Financing) on May 2, 2024.
Who to call at Aptose Biosciences, and when
A new round usually means Aptose Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aptose Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aptose Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aptose Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aptose Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Aptose Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.